Yi L

No ORCID on file · 7 papers in corpus
review 2026
Expert reviews in molecular medicine ·doi:10.1017/erm.2026.10050

BACKGROUND: Nerve growth factor (NGF), which acts on receptors tropomyosin receptor kinase A and p75 neurotrophic receptor, is a member of neurotrophin family and a kind of secretory polypeptides. METHODS: A comprehensive literature search…

2026
Materials today. Bio ·doi:10.1016/j.mtbio.2026.102763

Oral delivery of protein and peptide therapeutics (PPs) offers a non-invasive, patient-friendly alternative to parenteral administration, yet faces multiple formidable barriers due to the complex gastrointestinal (GI) environment. This revi…

other 2025
Frontiers in endocrinology ·doi:10.3389/fendo.2025.1550068

Extracellular vesicles (EVs) facilitate intercellular communication and the conveyance of bioactive substances, including proteins, lipids, and nucleic acids. They play a significant role in various reproductive biological processes, includ…

article 2019
Experimental and therapeutic medicine ·doi:10.3892/etm.2019.7522

Endometriosis is a common gynecological disease with manifestations of endometrial-like tissue outside the uterus. Transforming growth factor-β (TGF-β) is known to facilitate a series of biological events in many cells, including migration.…

2017
PloS one ·doi:10.1371/journal.pone.0170952

BackgroundThough moxibustion is frequently used to treat primary dysmenorrhea in China, relevant evidence supporting its effectiveness is still scanty.MethodsThis study was a pragmatic randomized, conventional drug controlled, open-labeled …

article 2015
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719115585145

BackgroundSeveral studies suggest that resistance to progesterone may contribute to the pathophysiology of endometriosis. Progesterone mediates its biological activity via the 2 progesterone receptor (PR) isoforms (PR-A and PR-B). Effects o…

2014
Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2014/434978

Dysmenorrhea is a prevalent problem in menstruating women. As a nonpharmacologic and free of relevant side effects intervention, moxibustion is considered as a safe treatment and has long been recommended for dysmenorrhea in China. However,…